Immuron IMRN
NASDAQ IMRN
$1.77 -0.07 (-3.80%)
As of: Sep 9, 2026 · 3:59 PM EDT

Immuron (IMRN) Total Current Liabilities (2015 - 2026)

Immuron (IMRN) posted Total Current Liabilities of $1.8 million for Q3 2026, down 9.19% on a QoQ basis from $2.0 million in Q4 2025, and up 8981.05% year-over-year from $19662.1 in Q3 2025.

Analysis

Immuron (IMRN) Total Current Liabilities (2015 - 2026) Analysis & Trends

Immuron has reported Total Current Liabilities for 12 years, with the latest figure at $1.8 million in Q3 2026.

  • On a quarterly basis, Total Current Liabilities rose 8981.05% year-over-year to $1.8 million in Q3 2026; TTM through Aug 2026 was $1.8 million, a 8981.05% increase from a year earlier, with the FY2026 full-year figure at $1.8 million, up 8981.05% from the prior year.
  • Total Current Liabilities was $1.8 million for Q3 2026 at Immuron, down from $2.0 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $2.0 million in Q4 2025, with the low at $17984.2 in Q3 2024.
  • Average Total Current Liabilities over 5 years is $1.2 million, with a median of $1.4 million recorded in 2023.
  • The sharpest annual moves came in 2023 and 2026: Total Current Liabilities sank 97.88% in 2023, then soared 8981.05% in 2026.
  • Over 5 years, Total Current Liabilities stood at $987488.0 in 2022, then soared by 46.29% to $1.4 million in 2023, then advanced by 22.18% to $1.8 million in 2024, then climbed by 11.4% to $2.0 million in 2025, then retreated by 9.19% to $1.8 million in 2026.
  • The last three Total Current Liabilities figures came in at $1.8 million (Q3 2026), $2.0 million (Q4 2025), and $19662.1 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 25.50 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 11.02 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 3.94 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 5.53 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 1.58 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 2.53 Bn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 1.51 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 3.92 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 283.60 Mn
10 Immuron 10.28 Mn 1.26 Mn - 1.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Aug 28, 2026 1.79 Mn
Dec 31, 2025 1.97 Mn
Sep 2, 2025 19,662.09
Jun 30, 2025 1.26 Mn
Dec 31, 2024 1.77 Mn
Sep 9, 2024 17,984.24
Jun 30, 2024 1.78 Mn
Dec 31, 2023 1.44 Mn
Sep 28, 2023 1.45 Mn
Aug 30, 2023 22,191.39
Jun 30, 2023 1.48 Mn
Dec 31, 2022 987,488.00
Aug 31, 2022 1.05 Mn
Jun 30, 2022 1.08 Mn
Dec 31, 2021 821,216.68
Sep 30, 2021 824,927.77
Jun 30, 2021 863,888.67
Dec 31, 2020 377,462.76
Sep 1, 2020 516,411.00
Jun 30, 2020 338,466.42